Skip to main content
Log in

Whole transcriptome sequencing reveals dexmedetomidine-improves postoperative cognitive dysfunction in rats via modulating lncRNA

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

The aim of this study was to explore the underlying mechanism and function of dexmedetomidine (Dex)-regulated long non-coding RNAs (lncRNAs) in improving postoperative cognitive dysfunction (POCD) in rats. The established POCD model, Dex treatment model in rats, Morris water maze testing, and HE staining assays were used to evaluate the efficacy of Dex in POCD treatment in rats. Hippocampus samples of rats from the POCD group and the Dex group were used for lncRNA sequencing. The expression of five differentially expressed lncRNAs (DElncRNAs) was verified by quantitative reverse transcription PCR (qRT-PCR). Competing endogenous RNAs (ceRNA) network was constructed using Cytoscape. The concentration of inflammatory cytokines were measured by ELISA. Microglia proliferation and apoptosis were assessed using CCK-8 assay and flow cytometry, respectively. In the Dex group, the escape latency was shorter, neuron cell injury levels were alleviated, and the expression levels of TNF-α and IL-1β were significantly down-regulated compared with the POCD group. A total of 60 DE lncRNAs were identified, including 16 up- and 44 down-regulated lncRNAs in the Dex group. KEGG pathway analysis revealed that DElncRNAs were significantly enriched in cytokine–cytokine receptor interactions, the p53 signaling pathway, and the NF-kappa B signaling pathway. The qRT-PCR results and ceRNA network suggested that the lncRNA LOC102546895 may play a key role in POCD. LOC102546895 inhibited proliferation while promoting apoptosis in microglial cells and promoted the mRNA and protein expression of the target gene Npas4. Our findings showed that Dex alleviated POCD in rats and regulated lncRNAs expression profile in the hippocampus tissues of rats with POCD. In conclusion, our study outcome proposes that Dex-regulated lncRNA LOC102546895 may play a role in rats with POCD through targeting Npas4.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

References

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: ZZ and GX. Data curation: ZZ and GX. Formal analysis: FD and LC. Funding acquisition: ZZ and GX. Investigation: FD, LC and BZ. Methodology: FD, LC and BZ. Software: FD. Writing—original draft: FD and LC. Writing—review and editing: FD, LC and BZ. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zhidong Zhou or GuoHai Xu.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Ethics approval and consent to participate

All rat experiments completely adhered to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health). All the experiments were approved by the Institutional Animal Care and Use Committee of the second affiliated hospital of Nanchang university.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 157 kb)

Supplementary file2 (PDF 85 kb)

Supplementary file3 (PDF 83 kb)

Supplement Table 4.

The specific information detailing DE lncRNAs (XLSX 15 kb)

Supplement Table 5.

The specific information detailing DE mRNAs (XLSX 57 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, F., Cai, L., Zhou, B. et al. Whole transcriptome sequencing reveals dexmedetomidine-improves postoperative cognitive dysfunction in rats via modulating lncRNA. 3 Biotech 10, 202 (2020). https://doi.org/10.1007/s13205-020-02190-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-020-02190-9

Keywords

Navigation